Fingerprint
Dive into the research topics of 'First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients
K. J. O'Byrne, K. H. Lee, S. W. Kim, K. Park, M. Nishio, H. Sakai, Y. Ohe, T. Fukuhara, J. H. Kang, H. Daga, C. J. Yu, K. Hotta, H. Tanaka, M. Takeda, T. Yokoyama, F. E. Nathan, J. S. Lee
Research output: Contribution to journal › Article › peer-review
5
Citations
(Scopus)